12:00 AM
 | 
Dec 20, 2010
 |  BC Week In Review  |  Clinical News  |  Clinical Status

EGEN-001: Phase II started

Egen said the Gynecologic Oncology Group (GOG) began an open-label Phase II trial in 56 patients to evaluate weekly intraperitoneal EGEN-001 in a 4-week...

Read the full 97 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >